M. Debled
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 5
- Cancer Diagnosis and Treatment 2
- HER2/EGFR in Cancer Research 2
-
- Advanced Breast Cancer Therapies 5
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- L. Mauriac (7 shared papers)Jean-Marc Ferrero (2 shared papers)G. Lorimier (1 shared paper)A. Avril (1 shared paper)J.M. Classe (1 shared paper)S. Giard (1 shared paper)Simone Mathoulin‐Pélissier (1 shared paper)Gaëtan MacGrogan (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Critical Reviews in Oncology/Hematology (2 papers)European Journal of Surgical Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
M. Debled
15 papers receiving 85 citations
Peers
Comparison fields: 5 of 23
- Cancer Research 46
- Oncology 54
- Geriatrics and Gerontology 2
- Pathology and Forensic Medicine 9
- Genetics 15
Countries citing papers authored by M. Debled
This map shows the geographic impact of M. Debled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Debled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Debled more than expected).
Fields of papers citing papers by M. Debled
This network shows the impact of papers produced by M. Debled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Debled. The network helps show where M. Debled may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Debled, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 23 | |
| 2 | 2011 | 18 | |
| 3 | 2021 | 15 | |
| 4 | 2006 | 10 | |
| 5 | 2006 | 5 | |
| 6 | 2008 | 5 | |
| 7 | 2010 | 2 | |
| 8 | 2016 | 2 | |
| 9 | 2006 | 2 | |
| 10 | [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma]. | 1997 | 2 |
| 11 | 2009 | 1 | |
| 12 | 2005 | 1 | |
| 13 | 2010 | 1 | |
| 14 | [Primary intraosseous rhabdomyosarcoma]. | 2000 | 1 |
| 15 | 2008 | 1 | |
| 16 | 2009 | 0 |
About M. Debled
M. Debled is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Surgery, having authored 16 papers that have together received 89 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Advanced Breast Cancer Therapies (5 papers), Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (4 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer Diagnosis and Treatment (2 papers), HER2/EGFR in Cancer Research (2 papers) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Cancer Research (46 citations), Oncology (54 citations), Geriatrics and Gerontology (2 citations), Pathology and Forensic Medicine (9 citations) and Genetics (15 citations). M. Debled has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include L. Mauriac, Jean-Marc Ferrero, G. Lorimier, A. Avril, J.M. Classe, S. Giard, Simone Mathoulin‐Pélissier, Gaëtan MacGrogan, G. Le Bouëdec and F. Lerebours. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Critical Reviews in Oncology/Hematology, European Journal of Surgical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.